Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
11 2022
Historique:
revised: 22 07 2022
received: 14 07 2022
accepted: 22 07 2022
pubmed: 3 8 2022
medline: 5 11 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

Since May 2022, a new outbreak of monkeypox has been reported in several countries, including Spain. The clinical and epidemiological characteristics of the cases in this outbreak may differ from those in earlier reports. To document the clinical and epidemiological characteristics of cases of monkeypox in the current outbreak. We conducted a prospective cross-sectional study in multiple medical facilities in Spain to describe the cases of monkeypox in the 2022 outbreak. In total, 185 patients were included. Most cases started with primarily localized homogeneous papules, not pustules, in the probable area of inoculation, which could be cutaneous or mucous, including single lesions. Generalized small pustules appeared later in some of them. Heterogeneous lesions occurred during this generalized phase. All patients had systemic symptoms. Less common lesions included mucosal ulcers (including pharyngeal ulcers and proctitis) and monkeypox whitlows. Four patients were hospitalized, none died. Smallpox vaccination and well-controlled HIV disease were not associated with markers of severity. Contact during sex is the most likely mechanism of transmission. In this outbreak, cases have been described in men who have sex with men and are strongly associated with high-risk sexual behaviours. Seventy-six per cent of the patients had other sexually transmitted diseases upon screening. The clinical findings in this outbreak differ from previous findings and highly suggest contact transmission and initiation at the entry site. The characterization of the epidemiology of this outbreak has implications for control. What is already known about this topic? Monkeypox eruption is described as consisting of pustules. The roles of HIV and previous smallpox vaccination in the prognosis are unknown. The transmission route was initially described as respiratory droplets and was later suggested to be via sexual contact. What does this study add? Initial lesions at the probable inoculation area were homogeneous and papular (pseudopustules). Generalized small pustules appeared later in some of them. Heterogeneous lesions occurred during this generalized phase. All patients had systemic symptoms. Less common signs included mucosal ulcers (including pharyngeal ulcers and proctitis) and monkeypox whitlows. Well-controlled HIV and previous smallpox vaccination were not associated with severity. No patient died. The data support the hypothesis of transmission via contact during sex. Although this might change, the outbreak is currently limited mostly to men who have sex with men, with high-risk factors for sexually transmitted diseases.

Sections du résumé

BACKGROUND
Since May 2022, a new outbreak of monkeypox has been reported in several countries, including Spain. The clinical and epidemiological characteristics of the cases in this outbreak may differ from those in earlier reports.
OBJECTIVES
To document the clinical and epidemiological characteristics of cases of monkeypox in the current outbreak.
METHODS
We conducted a prospective cross-sectional study in multiple medical facilities in Spain to describe the cases of monkeypox in the 2022 outbreak.
RESULTS
In total, 185 patients were included. Most cases started with primarily localized homogeneous papules, not pustules, in the probable area of inoculation, which could be cutaneous or mucous, including single lesions. Generalized small pustules appeared later in some of them. Heterogeneous lesions occurred during this generalized phase. All patients had systemic symptoms. Less common lesions included mucosal ulcers (including pharyngeal ulcers and proctitis) and monkeypox whitlows. Four patients were hospitalized, none died. Smallpox vaccination and well-controlled HIV disease were not associated with markers of severity. Contact during sex is the most likely mechanism of transmission. In this outbreak, cases have been described in men who have sex with men and are strongly associated with high-risk sexual behaviours. Seventy-six per cent of the patients had other sexually transmitted diseases upon screening.
CONCLUSIONS
The clinical findings in this outbreak differ from previous findings and highly suggest contact transmission and initiation at the entry site. The characterization of the epidemiology of this outbreak has implications for control. What is already known about this topic? Monkeypox eruption is described as consisting of pustules. The roles of HIV and previous smallpox vaccination in the prognosis are unknown. The transmission route was initially described as respiratory droplets and was later suggested to be via sexual contact. What does this study add? Initial lesions at the probable inoculation area were homogeneous and papular (pseudopustules). Generalized small pustules appeared later in some of them. Heterogeneous lesions occurred during this generalized phase. All patients had systemic symptoms. Less common signs included mucosal ulcers (including pharyngeal ulcers and proctitis) and monkeypox whitlows. Well-controlled HIV and previous smallpox vaccination were not associated with severity. No patient died. The data support the hypothesis of transmission via contact during sex. Although this might change, the outbreak is currently limited mostly to men who have sex with men, with high-risk factors for sexually transmitted diseases.

Identifiants

pubmed: 35917191
doi: 10.1111/bjd.21790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

765-772

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 British Association of Dermatologists.

Références

Yinka-Ogunleye A, Aruna O, Ogoina D et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis 2018; 24:1149-51.
Hutin YJ, Williams RJ, Malfait P et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001; 7:434-8.
Bunge EM, Hoet B, Chen L et al. The changing epidemiology of human monkeypox - a potential threat? A systematic review. PLOS Negl Trop Dis 2022; 16:e0010141.
Centers for Disease Control and Prevention. Monkeypox. Past U.S. cases and outbreaks. Available at: https://www.cdc.gov/poxvirus/monkeypox/outbreak/us-outbreaks.html (last accessed 26 July 2022).
World Health Organization. Multi-country monkeypox outbreak: situation update. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON393 (last accessed 26 July 2022).
Moreno DM, Escribano PC. Monkeypox virus infection: a case report. Actas Dermosifiliogr 2022; in press; doi: https://doi.org/10.1016/j.ad.2022.06.014.
European Centre for Disease Prevention and Control. Factsheet for health professionals on monkeypox. Available at: https://www.ecdc.europa.eu/en/all-topics-z/monkeypox/factsheet-health-professionals (last accessed 26 July 2022).
Brown K, Leggat PA. Human monkeypox: current state of knowledge and implications for the future. Trop Med Infect Dis 2016; 1:8.
Centers for Disease Control and Prevention. Monkeypox. Clinician FAQs. Available at: https://www.cdc.gov/poxvirus/monkeypox/clinicians/faq.html (last accessed 26 July 2022).
Basgoz N, Brown CM, Smole SC et al. Case 24-2022: a 31-year-old man with perianal and penile ulcers, rectal pain, and rash. N Engl J Med 2022; in press; doi: https://doi.org/10.1056/NEJMcpc2201244.
Ogoina D, Izibewule JH, Ogunleye A et al. The 2017 human monkeypox outbreak in Nigeria - report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLOS ONE 2019; 14:e0214229.
Reynolds MG, Davidson WB, Curns AT et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis 2007; 13:1332-9.
Huhn GD, Bauer AM, Yorita K et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 2005; 41:1742-51.
Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183:71-7.
Navarro Garcia R, Conde Rodelgo V, Herce Garraleta P et al. Instituto de Salud Carlos III. Analisis de la sanidad en España a lo largo del siglo XX [Analysis of healthcare in Spain throughout the 20th century]. Available at: http://hdl.handle.net/20.500.12105/4977 (last accessed 11 August 2022).
Petersen E, Kantele A, Koopmans M et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am 2019; 33:1027-43.
European Centre for Disease Prevention and Control (2022). Monkeypox multi-country outbreak: situation update, 25 July 2022. Available at: https://www.ecdc.europa.eu/en/monkeypox-outbreak (last accessed 26 July 2022).
Rahimi F, Talebi Bezmin Abadi A. The 2022 monkeypox outbreak: lessons from the 640 cases in 36 countries - correspondence. Int J Surg 2022; 104:106712.
Perez Duque M, Ribeiro S, Martins JV et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill 2022; 27:2200424.
Bayer-Garner IB. Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol 2005; 32:28-34.

Auteurs

Alba Català (A)

Sexually Transmitted Diseases Clinic, Dermatology Department, Hospital Clinic, Barcelona, Spain.

Petunia Clavo-Escribano (P)

Centro Sandoval, Dermatology Department, Hospital Clínico San Carlos, Madrid, Spain.

Josep Riera-Monroig (J)

Sexually Transmitted Diseases Clinic, Dermatology Department, Hospital Clinic, Barcelona, Spain.

Gemma Martín-Ezquerra (G)

Sexually Transmitted Diseases Clinic, Dermatology Department, Hospital del Mar, Barcelona, Spain.

Pablo Fernandez-Gonzalez (P)

Dermatology Department, Hospital Ramon y Cajal, Madrid, Spain.

Leonor Revelles-Peñas (L)

Centro Sandoval, Dermatology Department, Hospital Clínico San Carlos, Madrid, Spain.
Dermatology Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.

Ana Simon-Gozalbo (A)

Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.

Francisco José Rodríguez-Cuadrado (FJ)

Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Vanessa Guilera Castells (VG)

STDs Program, Hospital Clinic Barcelona, Spain.

Francisco Javier de la Torre Gomar (FJ)

Dermatology Department, Hospital Universitario San Cecilio, Granada, Spain.

Alicia Comunión-Artieda (A)

Centro de Diagnóstico Montesa, Madrid, Spain.

Laura de Fuertes de Vega (L)

Dermatology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

José Luis Blanco (JL)

Infectious Diseases & AIDS Unit, Hospital Clinic Barcelona, Spain.

Susana Puig (S)

Dermatology Department, Hospital Clinic, Barcelona, Spain.

Ángela María García-Miñarro (ÁM)

Hospital Universitario De Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.

Esther Fiz Benito (E)

Dermatology Department, Hospital La Paz, Madrid, Spain.

Carlos Muñoz-Santos (C)

Dermatology Department, Hospital General de Granollers, Granollers, Barcelona, Spain.

Juan Bosco Repiso-Jiménez (JB)

Dermatology Department, Hospital Costa del Sol, Marbella, Spain.

Cristina López Llunell (C)

Dermatology, Consorci Corporació Sanitària Parc Taulí, Barcelona, Spain.

Carmen Ceballos-Rodríguez (C)

Dermatology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

Víctor García Rodríguez (V)

Dermatology Department, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain.

Juan Luis Castaño Fernández (JL)

Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Irene Sánchez-Gutiérrez (I)

Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Ricardo Calvo-López (R)

Emergency Department, Hospital Universitario A Coruña, A Coruña, Spain.

Emilio Berna-Rico (E)

Dermatology Department, Hospital Ramon y Cajal, Madrid, Spain.

Belén de Nicolás-Ruanes (B)

Dermatology Department, Hospital Ramon y Cajal, Madrid, Spain.

Francesca Corella Vicente (F)

Dermatology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.

Eloy José Tarín Vicente (EJ)

Dermatology Department, Hospital 12 de Octubre, Madrid, Spain.

Laura de la Fernández de la Fuente (L)

Dermatology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain.

Nuria Riera-Martí (N)

Dermatology Department, Hospital Universitari Parc Tauli, Barcelona, Spain.

Miguel Angel Descalzo-Gallego (MA)

Research Unit, Fundacion Piel Sana AEDV, Madrid, Spain.

Mercè Grau-Perez (M)

Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Research Unit, Fundacion Piel Sana AEDV, Madrid, Spain.

Ignacio García-Doval (I)

Research Unit, Fundacion Piel Sana AEDV, Madrid, Spain.
Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.

Irene Fuertes (I)

Sexually Transmitted Diseases Clinic, Dermatology Department, Hospital Clinic, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH